These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8079523)

  • 1. [The effect of the Yersinia pestis capsular antigen on the 5'-nucleotidase activity of macrophages from mice of different strains].
    Kirillicheva GB; Naumov AV; Taranenko TM; Serdobintsev LN; Solov'eva MS; Baturina IG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):105-6. PubMed ID: 8079523
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interleukin-1 induction by different antigens and strains of Yersinia pestis bacteria in immunized mice].
    Ledvanov MIu; Emel'ianova NV; Pronin AV; Drozdov IG; Brandzishevskiĭ IuV; Shvedun GP; Taranenko TM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):10-3. PubMed ID: 8067103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The protective activity of the adhesion pili of Yersinia pestis].
    Vodop'ianov SO; Rybianets AA; Verkina LM; Romanova LV; Sorokina TB; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):26-9. PubMed ID: 8525726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant effect of anti-idiotypic antibodies to Yersinia pestis lipopolysaccharide.
    Feodorova VA; Devdariani ZL; Nazarova LS
    J Med Microbiol; 1999 Aug; 48(8):751-756. PubMed ID: 10450998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The characteristics of the action of the capsular antigen of Yersinia pestis on cells from plague-susceptible and -insusceptible rodents].
    Kagramanov VS; Aseeva LE; Varivoda TIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):13-6. PubMed ID: 10851982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative incidence of detection of specific antibodies to Yersinia pestis capsular antigen and lipopolysaccharide in humans immunized with pest vaccine].
    Devdariani ZL; Fedorova VA; Gromova OV; Taranenko TM
    Klin Lab Diagn; 1997 Apr; (4):39-41. PubMed ID: 9221077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New data on the specificity and genetic control of the capsular antigen (F1) in Yersinia pestis].
    Kosse LV; Lebedeva SA; Kuznetsova LS; Cherniavskaia AS; Zarenkov MI
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):29-33. PubMed ID: 9245136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interrelationship of the capacity for the expression of different serovariants of the Yersinia pestis capsular antigen with the degree of reduction of the lipopolysaccharide of the bacterial cells].
    Gremiakova TA; Anisimov AP; Zakharova NM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):3-6. PubMed ID: 7778370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the antigens and strains of Yersinia pestis with the expression of different immunogenicity and virulence determinants on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):4-5. PubMed ID: 8553746
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.
    Thomas RE; Simpson WJ; Perry LL; Schwan TG
    Am J Trop Med Hyg; 1992 Jul; 47(1):92-7. PubMed ID: 1386197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 12. [The comparative characteristics of preparations of Yersinia pestis capsular antigen F1 obtained from producer strains with different lipopolysaccharide structures].
    Gremiakova TA; Stepanshina VN; Negriĭ VF; Korobova OV; Anisimov GA; Apollonin AV; Likhoded VG
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):10-4. PubMed ID: 7941851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity to mouse toxin and level of macrophage 5-nucleotidase activity].
    Kirillicheva GB; Naumov AV; Taranenko TM; Solov'eva MS; Andreeva IP
    Biull Eksp Biol Med; 1992 Mar; 113(3):297-9. PubMed ID: 1421233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The genetic control of the F1-specific components of the capsular antigen in Yersinia pestis].
    Kosse LV; Nekliaeva VN; Lebedeva SA; Zarenkov MI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (5):81-5. PubMed ID: 10852029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characterization of the protective properties of antiplague preparations by using the index of macrophage subpopulation redistribution].
    Vasil'eva GI; Tkachenko LN; Verkina LM; Doroshenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):94-6. PubMed ID: 7879567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of immunomodulating effect of histamine in inbred strain mice].
    Kirillicheva GB; Solov'eva MS; Baturina IG; Shchukovskaia TN; Maslennikov GA
    Biull Eksp Biol Med; 1992 Mar; 113(3):296-7. PubMed ID: 1421232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of plague microbe fraction 1 protein-polysaccharide complex and pure protein on metabolic parameters of macrophages].
    Kirillicheva GB; Naumov AV; Ledvanov MIu; Stukova NIu; Baturina IG; Taranenko TM; Serdobintsev LN; Plotnikov OP
    Biull Eksp Biol Med; 1993 May; 115(5):494-6. PubMed ID: 8043831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological activity of the components of F1-antigen of Yersinia pestis].
    Kosse LV; Lebedeva SA; Cherniavskaia AS; Nekliaev VN; Markina OV; Morozova IV; Eremenko NS; Sal'nikova OI
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):76-81. PubMed ID: 16830596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
    Morton M; Garmory HS; Perkins SD; O'Dowd AM; Griffin KF; Turner AK; Bennett AM; Titball RW
    Vaccine; 2004 Jun; 22(20):2524-32. PubMed ID: 15193377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.